1. Pediatric drug labeling: improving the safety and efficacy of pediatric therapies;Roberts;JAMA,2003
2. Regulation (EC) No. 1901/2006 of the European Parliament and of the Council of 12 December 2006 on medicinal products for paediatric use and amending Regulation (EEC) No. 1768/92, Directive 2001/20/EC, Directive 2001/83/EC and Regulation (EC) No. 726/2004 (Text with EEA relevance). ; [accessed 1.03.09].
3. Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 on the approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use. ; [accessed 01.03.09].
4. Statutory pediatric informations available for anticancer drugs: inventory and proposals;Thouvenel;Arch Pediatr,2002
5. AVOREN Trial investigators. Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, ouble-blind phase III trial;Escudier;Lancet,2007